RGNX logo

REGENXBIO (RGNX) Working Capital

Annual Working Capital

$204.70 M
-$80.84 M-28.31%

December 31, 2023


Summary


Performance

RGNX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGNXbalance sheetmetrics:

Quarterly Working Capital

$210.67 M
-$37.74 M-15.19%

September 30, 2024


Summary


Performance

RGNX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGNXbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

RGNX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.3%-15.2%
3 y3 years-54.5%-30.6%
5 y5 years-35.2%-35.9%

RGNX Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-47.3%at low-45.8%+2.9%
5 y5-year-54.5%at low-53.2%+2.9%
alltimeall time-54.5%+3424.1%-53.2%+3521.1%

REGENXBIO Working Capital History

DateAnnualQuarterly
Sep 2024
-
$210.67 M(-15.2%)
Jun 2024
-
$248.41 M(-12.9%)
Mar 2024
-
$285.24 M(+39.3%)
Dec 2023
$204.70 M(-28.3%)
$204.70 M(-14.2%)
Sep 2023
-
$238.49 M(-8.6%)
Jun 2023
-
$260.92 M(-5.8%)
Mar 2023
-
$276.87 M(-3.0%)
Dec 2022
$285.54 M(-26.5%)
$285.54 M(-8.8%)
Sep 2022
-
$313.09 M(-10.8%)
Jun 2022
-
$350.87 M(+7.3%)
Mar 2022
-
$326.94 M(-15.8%)
Dec 2021
$388.35 M(-13.7%)
$388.35 M(+28.0%)
Sep 2021
-
$303.39 M(-12.3%)
Jun 2021
-
$345.83 M(-16.6%)
Mar 2021
-
$414.68 M(-7.8%)
Dec 2020
$449.75 M(+44.4%)
$449.75 M(+39.1%)
Sep 2020
-
$323.34 M(+11.9%)
Jun 2020
-
$288.88 M(-5.7%)
Mar 2020
-
$306.44 M(-1.6%)
Dec 2019
$311.36 M
$311.36 M(-5.3%)
DateAnnualQuarterly
Sep 2019
-
$328.88 M(-1.8%)
Jun 2019
-
$334.83 M(+18.5%)
Mar 2019
-
$282.49 M(-10.5%)
Dec 2018
$315.74 M(+105.6%)
$315.74 M(-14.0%)
Sep 2018
-
$367.24 M(+32.9%)
Jun 2018
-
$276.42 M(+11.5%)
Mar 2018
-
$247.84 M(+61.4%)
Dec 2017
$153.56 M(+83.5%)
$153.56 M(-3.3%)
Sep 2017
-
$158.76 M(+2.9%)
Jun 2017
-
$154.35 M(+11.2%)
Mar 2017
-
$138.84 M(+65.9%)
Dec 2016
$83.70 M(-26.5%)
$83.70 M(+1.8%)
Sep 2016
-
$82.24 M(-7.3%)
Jun 2016
-
$88.76 M(-11.1%)
Mar 2016
-
$99.80 M(-12.3%)
Dec 2015
$113.81 M(-1948.1%)
$113.81 M(-45.9%)
Sep 2015
-
$210.18 M(+159.3%)
Jun 2015
-
$81.05 M(-1416.2%)
Dec 2014
-$6.16 M(+151.8%)
-$6.16 M
Dec 2013
-$2.45 M
-

FAQ

  • What is REGENXBIO annual working capital?
  • What is the all time high annual working capital for REGENXBIO?
  • What is REGENXBIO annual working capital year-on-year change?
  • What is REGENXBIO quarterly working capital?
  • What is the all time high quarterly working capital for REGENXBIO?
  • What is REGENXBIO quarterly working capital year-on-year change?

What is REGENXBIO annual working capital?

The current annual working capital of RGNX is $204.70 M

What is the all time high annual working capital for REGENXBIO?

REGENXBIO all-time high annual working capital is $449.75 M

What is REGENXBIO annual working capital year-on-year change?

Over the past year, RGNX annual working capital has changed by -$80.84 M (-28.31%)

What is REGENXBIO quarterly working capital?

The current quarterly working capital of RGNX is $210.67 M

What is the all time high quarterly working capital for REGENXBIO?

REGENXBIO all-time high quarterly working capital is $449.75 M

What is REGENXBIO quarterly working capital year-on-year change?

Over the past year, RGNX quarterly working capital has changed by -$37.74 M (-15.19%)